Loading
Latest filing published 19 Nov 2021 for Gritstone bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Raphael Rousseau discloses dealings in Gritstone bio, Inc. to SEC (Form 4). Between 7 January 2021 and 27 May 2021, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 19 November 2021 came the latest disclosure, a share grant in Gritstone bio, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations